We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
580 result(s) found, displaying 181 to 190
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Prescription medicine registrationActive ingredients: fingolimod hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ILUMYA tildrakizumab (rch) 100 mg/1 mL solution for injection pre-filled syringe.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.